Kawamura A - Search Results

1

A Risk Model for 1-Year Mortality After Transcatheter Aortic Valve Replacement From the J-TVT Registry.

Maeda K, Kumamaru H, Kohsaka S, Shimamura K, Mizote I, Yamashita K, Kawamura A, Mukai T, Nakamura D, Takeda Y, Shimizu H, Sakata Y, Kuratani T, Miyagawa S, Sawa Y. Maeda K, et al. Among authors: kawamura a. JACC Asia. 2022 Oct 4;2(5):635-644. doi: 10.1016/j.jacasi.2022.06.002. eCollection 2022 Oct. JACC Asia. 2022. PMID: 36518724 Free PMC article.

2

N-glycans: phenotypic homology and structural differences between myocardial cells and induced pluripotent stem cell-derived cardiomyocytes.

Kawamura T, Miyagawa S, Fukushima S, Yoshida A, Kashiyama N, Kawamura A, Ito E, Saito A, Maeda A, Eguchi H, Toda K, Lee JK, Miyagawa S, Sawa Y. Kawamura T, et al. Among authors: kawamura a. PLoS One. 2014 Oct 30;9(10):e111064. doi: 10.1371/journal.pone.0111064. eCollection 2014. PLoS One. 2014. PMID: 25357199 Free PMC article.

3

Structural Changes in N-Glycans on Induced Pluripotent Stem Cells Differentiating Toward Cardiomyocytes.

Kawamura T, Miyagawa S, Fukushima S, Kashiyama N, Kawamura A, Ito E, Saito A, Maeda A, Eguchi H, Toda K, Miyagawa S, Okuyama H, Sawa Y. Kawamura T, et al. Among authors: kawamura a. Stem Cells Transl Med. 2015 Nov;4(11):1258-64. doi: 10.5966/sctm.2015-0029. Epub 2015 Sep 16. Stem Cells Transl Med. 2015. PMID: 26378261 Free PMC article.

4

Teratocarcinomas Arising from Allogeneic Induced Pluripotent Stem Cell-Derived Cardiac Tissue Constructs Provoked Host Immune Rejection in Mice.

Kawamura A, Miyagawa S, Fukushima S, Kawamura T, Kashiyama N, Ito E, Watabe T, Masuda S, Toda K, Hatazawa J, Morii E, Sawa Y. Kawamura A, et al. Among authors: kawamura t. Sci Rep. 2016 Jan 14;6:19464. doi: 10.1038/srep19464. Sci Rep. 2016. PMID: 26763872 Free PMC article.

5

Cardiomyocytes Derived from MHC-Homozygous Induced Pluripotent Stem Cells Exhibit Reduced Allogeneic Immunogenicity in MHC-Matched Non-human Primates.

Kawamura T, Miyagawa S, Fukushima S, Maeda A, Kashiyama N, Kawamura A, Miki K, Okita K, Yoshida Y, Shiina T, Ogasawara K, Miyagawa S, Toda K, Okuyama H, Sawa Y. Kawamura T, et al. Among authors: kawamura a. Stem Cell Reports. 2016 Mar 8;6(3):312-20. doi: 10.1016/j.stemcr.2016.01.012. Epub 2016 Feb 18. Stem Cell Reports. 2016. PMID: 26905198 Free PMC article.

6

Development of PET Imaging to Visualize Activated Macrophages Accumulated in the Transplanted iPSc-Derived Cardiac Myocytes of Allogeneic Origin for Detecting the Immune Rejection of Allogeneic Cell Transplants in Mice.

Kashiyama N, Miyagawa S, Fukushima S, Kawamura T, Kawamura A, Yoshida S, Harada A, Watabe T, Kanai Y, Toda K, Hatazawa J, Sawa Y. Kashiyama N, et al. Among authors: kawamura t, kawamura a. PLoS One. 2016 Dec 8;11(12):e0165748. doi: 10.1371/journal.pone.0165748. eCollection 2016. PLoS One. 2016. PMID: 27930666 Free PMC article.

7

Right Ventricular Outflow Tract Obstruction Due to Immunoglobulin G4-Related Disease.

Ishida M, Sakaguchi T, Miyagawa S, Nishi H, Yoshikawa Y, Fukushima S, Kawamura A, Ueno T, Ishibashi-Ueda H, Sawa Y. Ishida M, et al. Among authors: kawamura a. Ann Thorac Surg. 2017 Mar;103(3):e235-e237. doi: 10.1016/j.athoracsur.2016.08.104. Ann Thorac Surg. 2017. PMID: 28219555

8

Immunologic targeting of CD30 eliminates tumourigenic human pluripotent stem cells, allowing safer clinical application of hiPSC-based cell therapy.

Sougawa N, Miyagawa S, Fukushima S, Kawamura A, Yokoyama J, Ito E, Harada A, Okimoto K, Mochizuki-Oda N, Saito A, Sawa Y. Sougawa N, et al. Among authors: kawamura a. Sci Rep. 2018 Feb 27;8(1):3726. doi: 10.1038/s41598-018-21923-8. Sci Rep. 2018. PMID: 29487310 Free PMC article.

9

Rapid Deployment Aortic Valve Replacement via Right Lateral Mini-Thoracotomy　- First Clinical Experience in Japan.

Hata H, Toda K, Miyagawa S, Yoshikawa Y, Kainuma S, Yoshioka D, Kawamura T, Kawamura A, Yoshida S, Sawa Y. Hata H, et al. Among authors: kawamura t, kawamura a. Circ J. 2019 Jan 25;83(2):485-487. doi: 10.1253/circj.CJ-18-1090. Epub 2018 Dec 19. Circ J. 2019. PMID: 30568049 Free article.

10

Tumorigenicity assay essential for facilitating safety studies of hiPSC-derived cardiomyocytes for clinical application.

Ito E, Miyagawa S, Takeda M, Kawamura A, Harada A, Iseoka H, Yajima S, Sougawa N, Mochizuki-Oda N, Yasuda S, Sato Y, Sawa Y. Ito E, et al. Among authors: kawamura a. Sci Rep. 2019 Feb 13;9(1):1881. doi: 10.1038/s41598-018-38325-5. Sci Rep. 2019. PMID: 30760836 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,233 results

Search Page

Filters